{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:55:58Z","timestamp":1790222158256,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to analyze the clinical features of anti-SAE antibodies in Chinese myositis patients in comparison with different cohorts. The anti-SAE antibodies were tested in myositis patients and in control subjects. Long-term follow-up was conducted on the antibody-positive patients. Anti-SAE antibodies were exclusively present in 12 out of 394 (3.0%) adult dermatomyositis (DM) patients. Of the anti-SAE-positive DM patients, 75% had distinctive diffuse dark-red or pigment-like skin rashes, and 67% of these patients experienced mild muscle weakness. Muscular biopsies showed mild pathological manifestations. Compared with the antibody-negative group, the average age of dermatomyositis onset in the antibody-positive group was higher, and dysphagia occurred more frequently noted (<jats:italic>p<\/jats:italic>\u2009=\u20090.012). Only 9 patients received follow-up, 7 experienced improvement after treatment. The anti-SAE antibody levels correlated with improved disease condition. The anti-SAE antibody was found exclusively in adult DM patients, occurring infrequently in Chinese patients. In addition to a diffuse dark-red or pigment-like skin rash and mild muscular weakness, common symptoms included propensity for developing dysphagia. Serum levels of the anti-SAE antibody correlated with myositis disease activity, and anti-SAE-positive patients were responsive to treatment.<\/jats:p>","DOI":"10.1038\/s41598-017-00240-6","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T13:00:04Z","timestamp":1489064404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts"],"prefix":"10.1038","volume":"7","author":[{"given":"Yongpeng","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"240_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","volume":"15","author":"A Ghirardello","year":"2013","unstructured":"Ghirardello, A. et al. Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep \n                           15, 335 (2013).","journal-title":"Curr Rheumatol Rep"},{"key":"240_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","volume":"24","author":"L Casciola-Rosen","year":"2012","unstructured":"Casciola-Rosen, L. & Mammen, A. L. Myositis autoantibodies. Curr Opin Rheumatol \n                           24, 602\u20138 (2012).","journal-title":"Curr Opin Rheumatol"},{"key":"240_CR3","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/art.22862","volume":"56","author":"Z Betteridge","year":"2007","unstructured":"Betteridge, Z., Gunawardena, H., North, J., Slinn, J. & McHugh, N. Identifcation of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum \n                           56, 3132\u20137 (2007).","journal-title":"Arthritis Rheum"},{"key":"240_CR4","doi-asserted-by":"crossref","unstructured":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis 68, 1621\u20135 (2009).","DOI":"10.1136\/ard.2008.097162"},{"key":"240_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","volume":"31","author":"E Tarricone","year":"2012","unstructured":"Tarricone, E., Ghirardello, A., Rampudda, M., Bassi, N., Punzi, L. & Doria, A. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods \n                           31, 128\u201334 (2012).","journal-title":"J Immunol Methods"},{"key":"240_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","volume":"72","author":"M Fujimoto","year":"2013","unstructured":"Fujimoto, M. et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis \n                           72, 151\u20133 (2013).","journal-title":"Ann Rheum Dis"},{"key":"240_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/08916934.2012.755958","volume":"46","author":"Y Muro","year":"2013","unstructured":"Muro, Y., Sugiura, K. & Akiyama, M. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity \n                           46, 279\u201384 (2013).","journal-title":"Autoimmunity"},{"key":"240_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki, L., Nagy-Vincze, M., Griger, Z., Betteridge, Z., Sz\u00f6ll\u0151si, L. & Dank\u00f3, K. Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev \n                           13, 1211\u20139 (2014).","journal-title":"Autoimmun Rev"},{"key":"240_CR9","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/rheumatology\/kev247","volume":"54","author":"Y Muro","year":"2015","unstructured":"Muro, Y., Sugiura, K., Nara, M., Sakamoto, I., Suzuki, N. & Akiyama, M. High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis. Rheumatology (Oxford) \n                           54, 1745\u20137 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"240_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto, M. et al. Myositis-Specific Anti-155\/140 Autoantibodies Target Transcription Intermediary Factor 1 Family Proteins. Arthritis Rheum. \n                           64, 513\u201322 (2012).","journal-title":"Arthritis Rheum."},{"key":"240_CR11","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino, D. F. et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum \n                           65, 2954\u201362 (2013).","journal-title":"Arthritis Rheum"},{"key":"240_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med \n                           292, 344\u20137 (1975).","journal-title":"N Engl J Med"},{"key":"240_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med \n                           292, 403\u20137 (1975).","journal-title":"N Engl J Med"},{"key":"240_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider, L. G. et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) \n                           62, 465\u201372 (2010).","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"240_CR15","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/art.20349","volume":"50","author":"SM Sultan","year":"2004","unstructured":"Sultan, S. M. et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum \n                           50, 2281\u201390 (2004).","journal-title":"Arthritis Rheum"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00240-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:12:03Z","timestamp":1671765123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00240-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["240"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-00240-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]},"assertion":[{"value":"11 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"188"}}